Ann Moriarty
20Patents
8h-index
22Co-inventors
75Inventor score
Filing activity: Sep 7, 1984 → Jan 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4818527A | T cell epitopes of the hepatitis B virus nucleocapsid protein | Emerging Cross-Sectional Technologies | 52 | Expired |
| US5143726A | T cell epitopes of the hepatitis B virus nucleocapsid protein | Emerging Cross-Sectional Technologies | 52 | Expired |
| US4882145A | T cell epitopes of the hepatitis B virus nucleocapsid protein | Emerging Cross-Sectional Technologies | 44 | Expired |
| US6461867B1 | Synthetic antigen presenting matrix | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5820858A | Methods and compositions for inhibiting CD14 mediated cell activation | Physics | 14 | Expired |
| US4777240A | SV40 expression vector containing HBxAg as an expression marker | Emerging Cross-Sectional Technologies | 13 | Expired |
| US8124408B2 | Preparation of inactivated artificial antigen presenting cells and their use in cell therapies | Human Necessities | 10 | Active |
| US7993638B2 | Cancer treatment combining lymphodepleting agent with CTLs and cytokines | Human Necessities | 10 | Active |
| US4942125A | SV40 expression vector containing HBxAg as an expression marker | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6444206B1 | Methods and compositions for inhibiting CD14 mediated cell activation | Physics | 7 | Expired |
| US6828150B2 | Antigen presenting system and methods for activation of T-cells | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7326569B2 | Hybrid cells producing monoclonal anti-CD14 antibodies | Physics | 5 | Expired |
| US5753504A | Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8357533B2 | Preparation of inactivated artificial antigen presenting cells and their use in cell therapies | Human Necessities | 3 | Active |
| US5534405A | Antibodies, diagnostic systems and methods for assaying HBxAg | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5183734A | Antibodies, diagnostic systems and methods for assaying SV40 HBxAg | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9222070B2 | Cell therapy method for the treatment of tumors | Chemistry; Metallurgy | 0 | Active |
| US6884417B2 | Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6232080A | Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9222071B2 | Cell therapy method for the treatment of tumors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.